編審人員: 臺大醫院護理部 洪敏瑛督導長
本文出處:“Obesity and Cancer was originally published by the National Cancer Institute.”
Garvey WT, Mechanick JI. Proposal for a scientifically correct and medically actionable disease classification system (ICD) for obesity. Obesity (Silver Spring) 2020; 28(3):484–492.
Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. New England Journal of Medicine 2010; 363(23):2211–2119.
Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: A pooled analysis of 20 prospective studies.PLoS Medicine 2014; 11(7):e1001673.
Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. New England Journal of Medicine e 2006; 355(8):763–778.
Cohen SS, Park Y, Signorello LB, et al. A pooled analysis of body mass index and mortality among African Americans. PLoS One 2014; 9(11):e111980.
Lange SJ, Kompaniyets L, Freedman DS, et al. Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 2–19 years - United States, 2018–2020. MMWR. Morbidity and Mortality Weekly Report2021; 70(37):1278–1283.
Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: Have they different risk factors? Journal of Clinical Oncology 2013; 31(20):2607–2618.
Dougan MM, Hankinson SE, Vivo ID, et al. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. International Journal of Cancer 2015; 137(3):625–637.
Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the International BEACON Consortium. International Journal of Epidemiology 2012; 41(6):1706–1718.
Chen Y, Liu L, Wang X, et al. Body mass index and risk of gastric cancer: A meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(8):1395–1408.
Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies. European Journal of Cancer 2012; 48(14):2137–2145.
Campbell PT, Newton CC, Freedman ND, et al. Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults. Cancer Research 2016; 76(20):6076–6083.
Wang F, Xu Y. Body mass index and risk of renal cell cancer: A dose-response meta-analysis of published cohort studies. International Journal of Cancer 2014; 135(7):1673–1686.
Sanfilippo KM, McTigue KM, Fidler CJ, et al. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension 2014; 63(5):934–941.
Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies. European Journal of Cancer 2011; 47(11):1606–1615.
Niedermaier T, Behrens G, Schmid D, et al. Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis. Neurology 2015; 85(15):1342–1350.
Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. International Journal of Cancer 2011; 129(7):1708–1717.
Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: A systematic review of prospective studies. PLoS One 2013; 8(1):e53916.
Li L, Gan Y, Li W, Wu C, Lu Z. Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta-analysis of observational studies. Obesity (Silver Spring) 2016; 24(8):1786–1802.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371(9612):569–578.
Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiologic Reviews 2014; 36:114–136.
Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncology;4(11):e181771.
Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Medicine 2012; 9(4):e1001200.
Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: An analysis from the ovarian cancer cohort consortium. Journal of Clinical Oncology 2016; 34(24):2888–2898.
Kitahara CM, Pfeiffer RM, Sosa JA, Shiels MS. Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995–2015). Journal of the National Cancer Institute 2020; 112(8):810–817.
Feigelson HS, Bodelon C, Powers JD, et al. Body mass index and risk of second cancer among women with breast cancer. Journal of the National Cancer Institute 2021;113(9):1156–1160.
Sung H, Hyun N, Leach CR, Yabroff KR, Jemal A. Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA 2020; 324(24):2521–2535.
Gibson TM, Park Y, Robien K, et al. Body mass index and risk of second obesity-associated cancers after colorectal cancer: A pooled analysis of prospective cohort studies. Journal of Clinical Oncology 2014; 32(35):4004–4011.
Friedenreich CM, Ryder-Burbidge C, McNeil J. Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms. Molecular Oncology2021; 15(3):790–800.
Liu XZ, Pedersen L, Halberg N. Cellular mechanisms linking cancers to obesity. Cell Stress 2021; 5(5):55–72.
Gallagher EJ, LeRoith D. Obesity and diabetes: The increased risk of cancer and cancer-related mortality. Physiological Reviews 2015; 95(3):727–748.
Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: New perspectives. Annual Review of Medicine 2010; 61:301–316.
Harrison SA, Diehl AM. Fat and the liver--a molecular overview. Seminars in Gastrointestinal Disease 2002; 13(1):3–16.
Seo BR, Bhardwaj P, Choi S. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Science Translational Medicine 2015; 7(301):301ra130.
Clarke MA, Fetterman B, Cheung LC, et al. Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer. Journal of Clinical Oncology 2018; 36(12):1184–1191.
Islami F, Goding Sauer A, Gapstur SM, Jemal A. Proportion of cancer cases attributable to excess body weight by US state, 2011–2015. JAMA Oncology 2019; 5(3):384–392.
Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden. CA: A Cancer Journal for Clinicians2019; 69(2):88–112.
Luo J, Hendryx M, Manson JE, et al. Intentional weight loss and obesity-related cancer risk. JNCI Cancer Spectrum 2019; 3(4):pkz054.
Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the Women's Health Initiative randomized clinical trials. JAMA Oncology 2015; 1(5):611–621.
Teras LR, Patel AV, Wang M, et al. Sustained weight loss and risk of breast cancer in women 50 years and older: A pooled analysis of prospective data. Journal of the National Cancer Institute 2020; 112(9):929–937.
Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: A systematic review and meta-analysis. Surgical Endoscopy 2013; 27(12):4449–4456.
Mackenzie H, Markar SR, Askari A, et al. Obesity surgery and risk of cancer. British Journal of Surgery 2018; 105(12):1650–1657.
Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Annals of Surgery 2019; 269(1):95–101.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 2003; 348(17):1625–1638.
Schmitz KH, Neuhouser ML, Agurs-Collins T, et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. Journal of the National Cancer Institute 2013; 105(18):1344–1354.
Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: A review. Journal of Clinical Oncology 2012; 30(30):3726–3733.
Gacci M, Sebastianelli A, Salvi M, et al. Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: Results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study. Scandinavian Journal of Urology 2014; 48(2):138–145.
Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: Findings from Intergroup Trial 0114. Journal of Clinical Oncology 2004; 22(4):648–657.
Teras LR, Kitahara CM, Birmann BM, et al. Body size and multiple myeloma mortality: A pooled analysis of 20 prospective studies. British Journal of Haematology 2014; 166(5):667–676.
Goodwin PJ, Segal RJ, Vallis M, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: The LISA trial. Journal of Clinical Oncology 2014; 32(21):2231–2239.
Harrigan M, Cartmel B, Loftfield E, et al. Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. Journal of Clinical Oncology 2016; 34(7):669–676.
Goodwin PJ. Obesity and breast cancer outcomes: How much evidence is needed to change practice? Journal of Clinical Oncology 2016; 34(7):646–648. Epub 2015 Dec 28. doi:
Ligibel JA, Barry WT, Alfano C, et al. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): Study design. NPJ Breast Cancer 2017; 3:37.
Sheflin AM, Whitney AK, Weir TL. Cancer-promoting effects of microbial dysbiosis. Current Oncology Reports 2014; 16(10):406.
Ringel AE, Drijvers JM, Baker GJ, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 2020; 183(7):1848–1866.
Bandera EV, Alfano CM, Qin B, et al. Harnessing nutrition and physical activity for breast cancer prevention and control to reduce racial/ethnic cancer health disparities. American Society of Clinical Oncology educational book 2021; 41:1–17.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403):157–163.
MacLean PS, Rothman AJ, Nicastro HL, et al. The Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures project: Rationale and approach. Obesity (Silver Spring) 2018; 26 Suppl 2(Suppl 2):S6–S15.
Bray MS, Loos RJ, McCaffery JM, et al. NIH working group report-using genomic information to guide weight management: From universal to precision treatment. Obesity (Silver Spring) 2016; 24(1):14–22.
編審人員: 臺大醫院護理部 洪敏瑛督導長
本文出處:“Obesity and Cancer was originally published by the National Cancer Institute.”